Clinical and Translational Radiation Oncology · 2019 · 36 citations · 37 references
MedicineOncologyRadiation OncologyDysphagiaSwallowing RehabilitationTreatment PlanningDysphagia AssessmentDysphagia ManagementOropharyngeal CancerOropharyngeal DysphagiaRadiation TherapySwallowing DisordersAging-related DysphagiaChronic Radiation EffectsConcurrent TherapyIntensity-modulated Radiation Therapy DosimetryIntrinsic Tongue MusclesRadiation Dose ConstraintsRadiation-associated DysphagiaRadiation-induced Dysphagia
Objectives: We sought to model chronic radiation-associated dysphagia (RAD) in patients given intensitymodulated radiation therapy (IMRT) for oropharyngeal squamous cell cancer (OPSCC) as a function of age and dose to non-target swallowing muscles. Methods: We reviewed 300 patients with T1-T4 N0-3 M0 OPSCC given definitive IMRT with concurrent chemotherapy. Chronic RAD was defined as aspiration or stricture on videoflouroscopy/endoscopy, gastrostomy tube, or aspiration pneumonia at 12 months after IMRT. Doses to autosegmented regions of interest (ROIs; inferior, middle and superior constrictors, anterior and posterior digastrics, mylo/geniohyoid complex, intrinsic tongue, and gengioglossus) were obtained from DICOM-RT plans and dose-volume histograms. The probability of chronic RAD as a function of mean ROI dose, stratified by age (<50, 50-59, 60-69, or 70 years), was estimated with logistic probability models and subsequent unsupervised nonlinear curves. Results: Chronic RAD was observed in 34 patients (11%). Age was a significant correlate of chronic RAD, both independently and with dose for all muscle groups examined. Distinct muscle-specific dose-response profiles were observed as a function of age (e.g., 5% of patients in their 50 s [but 20% of those 70 + ] who received 60 Gy to the superior constrictor had chronic RAD). This effect was stable across all observed muscle ROIs, with a false discovery rate-corrected p < 0.05, for all dose/muscle/age models, suggesting that including age as a covariate improves modeling of chronic RAD. Conclusions: Age at treatment moderates the probability of chronic RAD after chemo-IMRT for OPSCC, with aging muscles showing lower dose thresholds. Uniform dose constraints may not predict toxicity in older patients.
37
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text
Oropharyngeal swallowing in normal adults of different ages
JoAnne Robbins, John Hamilton, Gregory L. Lof et al. · Gastroenterology · 1992 · 670 citations
Health Professions, Otolaryngology, Speech-language Pathology +13
Felix Y. Feng, Hyungjin Myra Kim, Teresa Lyden et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 484 citations
Squamous cell carcinoma of the oropharynx
James T. Parsons, William M. Mendenhall, Scott P. Stringer et al. · Cancer · 2002 · 468 citations · Full text
Peter C. Levendag, David N. Teguh, P. Voet et al. · Radiotherapy and Oncology · 2007 · 417 citations